Most Recent
IP Australia has refused to register a patent acquired by Elanco Australasia from Bayer covering a lice treatment, after amendments failed to address findings that the patent lacked an inventive step.
Melbourne-based joint venture Shepparton Partners Collective has appealed a $1.2 million judgment which found it infringed software developer QAD's copyright by failing to pay a transfer fee to retain the licence after it acquired the iconic SPC Ardmona cannery in Victoria from Coca-Cola Amatil for $40 million.
For intellectual property barrister David Larish, one of the most pivotal moments in his career had nothing to do with working on a case.
An appeals court has upheld a ruling which bars use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a “disturbing” number of similarities with the marketing and appearance of an established competitor’s Rescue natural sleep aid product.
Lawyerly is pleased to announce the winners of its inaugural Litigation Rising Stars competition, which honours 30 lawyers under the age of 40 for their work in high-stakes litigation.
Arnott's and Campbells have settled a lawsuit brought by Goodman Fielder accusing them of infringing its 'Plantry' mark under which it sells plant-based frozen meals, after the cookie company filed a cross-claim seeking to have the mark cancelled.
Food giants Arnott's and Campbells have hit back in an infringement case over their 'Plantly' trade mark, filing a cross-claim that seeks to cancel rival Goodman Fielder's 'Plantry' mark.
A judge has issued an injunction temporarily barring use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a “disturbing” number of similarities with the marketing and appearance of an established competitor’s Rescue natural sleep aid product.
The Federal Court has delayed a 15-day hearing in a pneumococcal vaccine patent dispute between Merck Sharp & Dohme and Pfizer after the sudden death of a family member of one of Pfizer's expert witnesses.
Drug giant Merck Sharp & Dohme has brought a cross appeal in its long-running intellectual property dispute with Pfizer's Wyeth over the top selling Prevnar 13 pneumococcal vaccine.